Sign in with Google
|
USD 0.36
Price
0.01
(2.89%)
Day Change
|
|
|---|
RLMD, ファンダメンタルスコアはnot quite good (ファンダメンタル = 54) そしてテクニカルスコアは ...(Sign In to See)...
Loading chart...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
ROEが低い
ROAが低い
平均ROEが低い
昨年度のROEが一昨年比で低い
NPMが低い
NPMの伸びが低い
In details, quality factors are not good , financial health is not good , and ability to make profit is not good , ...
| Deepscope 分析 |
|
45% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| Social Score | 2 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 0.36 |
| PBV / Sector |
0.13 / 1.56
GREAT
|
| Earning Per Share | -2.86 |
| PE / Sector |
N/A / 16.11
|
| PEG or PE/Growth / Sector |
N/A / 5.60
|
| Average 1M Daily Value |
1.24 M
GREAT
|
| Average 1W Daily Value |
0.32 M
GREAT
|
| Timing Factors |
|
28% |
| Financial Health |
|
37% |
| ポイントになる統計 |
|
37% |
| 配当 |
|
4% |
| 登録情報 |
| Analyze Date | 2024-12-21 07:38:48 |
| Symbol | RLMD |
| Name | RELMADA THERAPEUTICS INC |
| Sector | Healthcare >> Biotechnology |
| Market | NASDAQ |
| Listed Shares | 30.17 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 10.64 / 3,466.05 |
| ニュース |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
EXEL 
RPRX 
UTHR 
